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Leishmaniasis are globally widespread parasitic diseases which often leads to death if left untreated.
Currently available drugs present different drawbacks, so there is an urgent need to develop new, safe
and cost-effective drugs against leishmaniasis. In this study we tested a small library of trans-stilbene
and terphenyl derivatives against promastigote, amastigotes and intramacrophage amastigote forms of
Leishmania infantum. Two compounds of the series, the trans-stilbene 3 and the terphenyl 11, presented
the best activity and safety proﬁles. Terphenyl 11 showed a leshmanicidal activity higher than pentostam
and the ability to induce apoptosis selectively in Leishmania infantum while saving macrophages and
primary epithelial cells. Our data indicate that terphenyl compounds, as well as stilbenes, are endowed
with leishmanicidal activity, showing potential for further studies in the context of leishmanial therapy.
© 2016 Elsevier Inc. All rights reserved.omotion Sciences, Section of
rtmental Research Centre on
Via del Vespro 129, 90127,
eo).1. Introduction
Leishmaniasis is a disease caused by an intracellular protozoan
parasite (Leishmania) transmitted by the bite of a sandﬂy. The
clinical spectrum of leishmaniasis ranges from a self-resolving
cutaneous ulcer to a mutilating mucocutaneous disease and even
to a lethal systemic illness. Most of the antileishmanial modern
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resistance and high cost of treatment (Monzote, 2009). The
pentavalent antimonial drugs are used as the ﬁrst line of treatment.
The two available preparations, sodium stibogluconate (pentos-
tam), produced in Great Britain, and meglumine antimonate (glu-
cantime), produced in France, have similar efﬁcacy. However, these
drugs can induce important side effects such as cardiotoxicity,
reversible renal failure, pancreatitis, anemia, leukopenia, rash,
headache, abdominal pain, nausea, vomiting, arthralgia, myalgia,
thrombocytopenia, and transaminase elevation. Moreover in the
past 15 years the resistance against these drugs have become a
clinical threat (Croft et al., 2006). Pentamidine, a pentavalent
antimonial drug used as standard ﬁrst-line treatment for leish-
maniasis, has been reported to cause ventricular arrhythmias and
nephrotoxicity. Recently, oral administration of miltefosine has
emerged as an alternative approach (Herwaldt, 1999). Unfortu-
nately, despite its great efﬁcacy, miltefosine is limited by its
extremely long half-life, low therapeutic index and development of
resistance (Sundar and Murray, 2005). Liposomal amphotericin B
has been used with increasing frequency to treat visceral leish-
maniasis. It is the treatment of choice for immunocompetent pa-
tients in the Mediterranean region and the preferred drug for HIV/
visceral leishmaniasis co-infection. However with the increasing
use of amphotericin B in lipid formulation having longer half-lives,
amphotericin B resistant mycoses are emerging (Croft et al., 2006).
Therefore, the possibility of amphotericin B resistance in leish-
maniasis cannot be ignored (Purkait et al., 2012; Brotherton et al.,
2014). So there is an urgent need to develop new, safe and cost-
effective drugs against leishmaniasis.
Natural products are potentially rich sources of novel active
molecules that may serve as lead or structural template for drug
discovery. In this context, in the last years several natural com-
pounds and their synthetic analogues have been tested against
Leishmania, and many of them have demonstrated potential as
leishmanicidal agents (Changtam et al., 2010; Tipparaju et al., 2008;
Marin et al., 2009; Mishra et al. 2009a,b; Hussain et al., 2014; Singh
et al., 2014). Stilbenes-based compounds are widely represented in
nature (Shen et al., 2009; Riviere et al., 2012) and have become of
particular interest to chemists and biologists because of their wide
range of biological effects including chemopreventive, antitumor,
antioxidant, antimicrobial, anti-inﬂammatory and antihistaminic
activities (Hart, 1981; Fremont, 2000; Young and Chaplin, 2004).
Recently, several natural and synthetic stilbenoids have been
studied for their leishmanicidal properties (del Rey et al., 1999; del
Olmo et al., 2001; Getti et al., 2006; Fuchino et al., 2013; de Almeida
Machado et al., 2015) and some of them, including resveratrol
(trans-3,40,5-trihydroxystilbene, Fig. 1) (Kedzierski et al., 2007;
Lucas and Kolodziej, 2013; Ferreiraa et al., 2014) and piceatannol
(trans-3,30,40,5-tetrahydroxystilbene, Fig. 1) (Duarte et al., 2008),
have shown anti-leishmania activity in vitro.
In light of the above, recently we described a study in which we
evaluated the anti-leishmanial activity of cis- and trans-stilbenes
(Tolomeo et al., 2013). All the tested cis-analogues were less potent
than their corresponding trans isomer. Compound 1, namely trans-
3,40,5-trimethoxy-30-amino-stilbene (TTAS, Fig. 1), was the most
active in Leishmania infantum (IC50 value of 2.6 mg/mL), while dis-
playing a low toxicity on normal hemopoietic cells.
To further explore the structure-activity relationships (SAR) of
this class of compounds we describe herein a study in which we
evaluated the antileishmanial activity of a second series of trans-
stilbenes derivatives, in which a variety of substituents were
introduced at positions 20, 30and 40 of the stilbene scaffold while the
3,5-dimethoxy motif was maintained (2e5, Fig. 1). Additionally as a
further development of this project, we study a series of terphenyl
derivatives (6e12, Fig. 1) incorporating a phenyl ring as abioisosteric substitution of the stilbene alkenyl bridge. Terphenyls
6e12 present the resveratrol-like pattern of oxygenated phenyl
rings, i.e., one para-substituted and one di-meta-substituted phenyl
connected by an unsaturated/aromatic system.
All the compounds evaluated herein were previously synthe-
sized by us with the aim of discovering new lead with anticancer
potential (Roberti et al., 2003, 2006; Pizzirani et al., 2008), except 4
that was reported by Kim et al. (2002). The compounds with the
higher antileishmanial activity and a safety proﬁle, i.e., no cytotoxic
were further used to characterize their biological properties.
2. Material and method
2.1. Parasites cultures
A strain of Leishmania infantum promastigotes zimodeme 1
(MHON/TN/80/IPT1 MON1) received from the Higher Institute of
Health of Rome (Italy) was cultured at 25 C and pH 7.18 in RPMI-PY
medium, which consisted of RPMI 1640 (Sigma R0883) supple-
mented with equal volume of Pepton-yeast medium, 10% fetal
bovine serum (FBS), 1% glutamine, 250 mg/mL gentamicin and
500 mg/mL of 5-ﬂuorocytosine (Castelli et al., 2014). To obtain
amastigotes cells, promastigotes were cultivated in RPMI-PY, in
which the pH was acidiﬁed with 1 N HCl to 5.4, and incubated at
37 C.
2.2. Promastigotes and amastigotes viability assay
Promastigotes or amastigotes of Leishmania infantum (4  106/
mL) were suspended in 25 cm2 ﬂasks (Falcon) containing 10 ml of
RPMI-PY medium and treated with serial concentrations of each
compound. After 48 h of treatment the parasites were cen-
trifugated and resuspended in 1 ml of RPMI-PY medium. The sus-
pension of Leishmania from each treatment was mixed with 0.4%
trypan blue solution at a ratio of 3:1 (vol/vol) (Dutta et al., 2005).
The percentage of vitality of Leishmania was observed by counting
in a Bürker hemocytometer for enumeration of stained and un-
stained cells, taken respectively as dead and living cells, in com-
parison with the control culture (100% viability).
2.3. Mammalian cell cytotoxicity
Potential cytotoxic action of each compound was checked by 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenylterazolium bromide (MTT)
assay on U937 (human Caucasian histiocytic lymphoma, ECACC
85011440, UK) and in primary epithelial cells of Cercopiteco (CPE).
U937 and CPE cells were cultured in RPMI 1640 (Sigma R0883)
supplemented with 10% fetal bovine serum (FBS, Gibco), penicillin
(100 IU/mL) and streptomycin (100 mg/mL). Cells were grown at
37 C in 5% CO2 and passaged twice a week. In each experiment,
cells (105/well) were incubated into 96-well plates overnight in a
humidiﬁed 5% CO2 atmosphere at 37 C to ensure cell adherence.
After 24 h, cells were treatedwith increasing concentrations of each
compound. Non-treated cells were included as a negative control.
After 48 h incubationwith each compound, theMTT (5mg/mL) was
added to eachwell and incubated at 37 C for 4 h. Then themedium
and MTT were removed, cells washed by PBS and 200 mL of DMSO
were added to dissolve the formazan crystals. The absorbance was
measured using a microplate reader Spectrostar Nano (BMG Lab-
Tech) at 570 nm. The reduction of MTT to insoluble formazan was
done by the mitochondrial enzymes of viable cells and so is an
indicator of cell viability. Therefore, decreases of absorbance indi-
cate toxicity to the cell. The viability was calculated using the
following formula: [(L2/L1)  100], where L1 is the absorbance of
control cells and L2 is the absorbance of treated cells. The 50%
Fig. 1. Structures of stilbene and terphenyl compounds: A) Resveratrol and piceatannol; B) trans-3,40 ,5-trimethoxy-30-amino-stilbene 1 (TTAS); C) trans-stilbenes 2e5; D) ter-
phenyls 6e12.
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decreases the rate of cell vitality by 50%, was calculated by
regression analysis (GraphPad software).
2.4. Effects of compounds in intracellular amastigotes
In order to evaluate the effects of compounds in cultures of
macrophages infected with Leishmania infantum a macrophage
infection protocol similar to that described by Sharma (Sharma
et al., 2011) was used with some modiﬁcations. U937 monocytic
cells (1  105 cells/mL) in the logarithmic phase of growth were
plated onto chamber Lab Tek culture slides in 2.5 mL of RPMI 1640
(Sigma), 10% FBS medium containing 25 ng/mL of phorbol 12-
myristate 13-acetate (PMA-Sigma) for 18 h to induce differentia-
tion (Maia et al., 2007). After incubation, the mediumwas removed
by washing twice with RPMI-1640 medium. Non adherent cells
were removed, and the macrophages were further incubated
overnight in RPMI 1640 medium supplemented with 10% FBS. Then
adherent macrophages were infected with Leishmania infantum
promastigotes at a parasite/macrophage ratio of 5:1 for 24 h at
37 C in 5% CO2. Free promastigotes were removed by three
extensive washing with RPMI-1640 medium, and infected macro-
phages were either incubated 48 h in media alone (infection con-
trol) or with serial concentrations of each compound. With the aim
of stain intracellular amastigotes, cells were ﬁxed with iced
methanol to permeabilize cell membrane to ethidium bromide and
stained with 100 mg/mL ethidium bromide (De Souza Leao et al.,
1995; Azzouz et al., 2005). The number of infected cells wasdetermined by examining three coverslips for each treatment. At
least 200 macrophages were counted by visual examination under
40 magniﬁcations by using a ﬂuorescence microscope Nikon
Eclipse E200 (Nikon Instruments Europe, Amsterdam, Netherlands)
to determine the number of resident amastigotes. The number of
resident amastigotes was expressed as percentage of the control.
2.5. Morphological analysis of cell death
To evaluate the type of parasite death (necrosis or apoptosis)
cells were stained with a mixture of acridine orange (100 mg/mL)
and ethidium bromide (100 mg/mL) (Liegler et al., 1995; Ribble et al.,
2005; Tolomeo et al., 2013). Promastigotes of Leishmania infantum
(4  106/ml) were suspended in 50 cm2 ﬂasks (Falcon) containing
10ml of RPMI-PYmedium and treated with each compound (10 mg/
mL). After 48 h of treatment promastigotes (1  106) were centri-
fuged and the pellet was resuspended in 25 mL of stained mixture
and examined in oil immersion with a 100x objective using a
ﬂuorescence microscope (Nikon Eclipse E200). The characteristic
nuclear phenotype exhibited by apoptotic cells (condensation of
genomic DNA) was used to distinguish between normal and
apoptotic cells. Viable or necrotic cells were identiﬁed by nuclei
with green or red ﬂuorescence, respectively. Apoptotic cells were
detected by their condensed nuclei. In early apoptosis, only acridine
orange will reach the nuclear material (green ﬂuorescence),
whereas, in the later phase, ethidium bromide will penetrate the
cells as well (red ﬂuorescence). Drug induced apoptosis and ne-
crosis was also determined morphologically in macrophages
Table 1
IC50 values (mg/ml) of trans-stilbene derivatives 1e5 and terphenyl derivatives 6e12
against promastigotes of Leishmania infantum.
Compound Structure IC50 mg/mL
1 (TTAS) 2.6 ± 0.4
2 10.7 ± 0.8
3 2.1 ± 0.3
4 11 ± 0.2
5 4.2 ± 0.6
Resveratrol >50
6 >50
7 5.3 ± 0.8
8 >50
9 3.8 ± 0.6
10 27 ± 4.1
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copiteco (CPE) after labeling with acridine orange and ethidium
bromide. Cells (2  105) were centrifuged and the pellet was
resuspended in 25 mL of the dye mixture. Ten microliters of the
mixturewas examined in oil immersionwith a 100x objective using
a ﬂuorescence microscope (Nikon Eclipse E200). Live cells were
determined by the uptake of acridine orange (green ﬂuorescence)
and exclusion of ethidium bromide (red ﬂuorescence) stain. Dead
apoptotic and necrotic cells were identiﬁed by perinuclear
condensation of chromatin stained by acridine orange or ethidium
bromide, respectively, and by the formation of apoptotic bodies.
The percentage of apoptotic cells was determined after counting at
least 300 cells.
2.6. Cell cycle analysis by ﬂow cytometry
Promastigotes (4  106) were incubated for 24 h with each
compounds (8 mg/mL) at 26 C. We use 8 mg/mL because the
treatment of promastigotes with 10 mg/mL caused a too large
recruitment of parasites in sub-G1 (apoptotic cells). Afterward, the
Leishmania infantum parasites were washed 3 times with PBS
containing 0.02 M EDTA to avoid clumps and were then ﬁxed with
cold methanol for 24 h. The parasites were resuspended in 0.5 mL
of PBS containing RNase I (50 mg/mL) and PI (25 mg/mL) and were
then incubated at 25 C for 20 min. The material was kept on ice
until analysis. The stained parasites were analyzed in single-
parameter frequency histograms by using a FACScan ﬂow cytom-
eter (Becton Dickinson, San Jose, CA).
2.7. Determination of apoptosis by Annexin V
Externalization of phosphatidylserine on the outer membrane
of parasites with and without treatment was determined by using
Annexin V labeling kit following the manufacturer's protocol
(Annexin-V-FITC Apoptosis Detection Kit Alexis, Lausen,
Switzerland) (Singh et al. 2005). Brieﬂy, promastigotes (2  106)
were washed with PBS and centrifuged at 500 g for 5 min. The
pellet was suspended in 100 mL of staining solution containing
FITC-conjugated Annex-in-V and propidium iodide (Annexin-V-
Fluos Staining Kit, Roche Molecular Biochemicals, Mannheim,
Germany) and incubated for 15 min at 20 C. Annexin V positive
parasites were determined by ﬂow cytometry (Becton Dickinson).
2.8. Statistical analysis
All susceptibility assays on Leishmania infantum promastigote
and amastigote cells were performed by two observers in three
replicates samples and repeated with three new batches of para-
sites. The mean and standard error of at least three experiments
were determined. The differences between the mean values ob-
tained for experimental groups were evaluated by the Student's t
test. P-values of 0.05 or less were considered signiﬁcant.
3. Results
3.1. Antileishmanial activity
Four trans-stilbenes derivatives (2e5, Table 1) and seven ter-
phenyl derivatives (6e12, Table 1) were tested in vitro in a strain of
Leishmania infantum promastigotes zimodeme 1 (MHON/TN/80/
IPT1 MON1) (Fig. 1). The activity of these compounds was
compared to that of pentostam, a pentavalent antimonial drug used
as the ﬁrst line of treatment of Leishmania infection and TTAS, a
trans-stilbene derivative previously studied by us and endowed
with potent anti-leishmanial activity (Tolomeo et al., 2013). The
Table 1 (continued )
Compound Structure IC50 mg/mL
11 1.4 ± 0.2
12 >50
Pentostam 2.1 ± 0.5
Values represent the mean ± SE for four independent experiments.
Table 2
IC50 (mg/mL) of 3 and 11 against promastigote, amastigote and intracellular amas-
tigote forms of Leishmania infantum.
Leishmania infantum cells Compounds
3 11
Promastigotes 2 ± 0.3 1.4 ± 0.2
Amastigotes 0.81 ± 0.09 0.65 ± 0.08
Intracellular Amastigotes 4.2 ± 0.7 3 ± 0.5
Values represent the mean ± SE for four independent experiments.
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viability (IC50) was used as the parameter for leishmanicidal ac-
tivity. As shown in Table 1 all trans-stilbene derivatives were
endowed with leishmanicidal activity with a IC50 ranging from
2.1 mg/mL to 11 mg/mL. The most active trans-stilbene of this series
was compound 3 that showed a leishmanicidal activity similar to
pentostam and TTAS. The range of activity of terphenyl compounds
(6e12) was very wide and the IC50 ranged from 1.4 mg/mL to more
than 50 mg/mL (Table 1). Of interest, terphenyl 11was slightly more
active than pentostan and TTAS. Based on leishmanicidal activity
data, compounds 3 and 11 were selected for further studies. In
Fig. 2a and 2b are reported the dose-response curves of 3 and 11 in
promastigotes and amastigotes respectively. Terphenyl 11 was
slightly more active than trans-stilbene 3 either in promastigotes or
in amastigotes. As shown in Fig. 2 and Table 2 both the compounds
were more active in amastigotes than in promastigotes.Fig. 3. Effects of compounds 3 and 11 in intracellular amastigotes. The number of
intracellular amastigotes in the samples treated with 3 and 11 was expressed as per-
centage of the number of intracellular amastigotes in the control. At least 200 mac-
rophages were counted by visual examination under 400 magniﬁcations by using a
ﬂuorescence microscopy to determine the number of resident amastigotes. Bars
indicate the mean ± SE from four independent experiments.3.2. Effects in intracellular amastigotes
Upon entering the mammalian host, Leishmania parasites
transform into the amastigote stage that reside inside the phag-
olysosomal vacuoles of macrophages. Therefore, it is important to
evaluate the antileishmanial activity on intracellular amastigotes of
any new potential compound. We evaluated the anti-amastigoteFig. 2. Promastigotes (a) and amastigotes (b) viability after 48 h exposure to increasing conc
experiments.efﬁcacy in U937 macrophage cells infected with Leishmania infan-
tum as reported in material and methods. A dose-dependent
decrease in the number of intra-macrophagic amastigotes was
observed both with compounds 3 and 11 (Figs. 3 and 4). The IC50
was 4.2 mg/mL and 3 mg/mL for 3 and 11 respectively (Table 2).3.3. Cytotoxic effects
In order to evaluate the toxicity of 3 and 11, primary epithelial
cells of Cercopiteco (CPE) and uninfected U937 macrophages were
treated with these compounds and cytotoxicity was evaluated afterentrations of compounds 3 and 11. Bars indicate the mean ± SE from four independent
Fig. 4. Morphology of untreated infected macrophages (a), infected macrophages
exposed to 10 mg/ml compound 3 for 48 h (b), and infected macrophages exposed to
10 mg/ml compound 11 for 48 h (c). Cells were ﬁxed with iced methanol to per-
meabilize the cell membrane to ethidium bromide, stained with ethidium bromide and
examined by using a ﬂuorescence microscopy. Data are representative of three sepa-
rate experiments.
G. Castelli et al. / Experimental Parasitology 166 (2016) 1e9648 h through MTT assay. For concentrations ranging from 1 mg/mL
to 12 mg/mL 3 and 11 did not caused any reduction in CPE viabilityFig. 5. Cytotoxic effects of compounds 3 and 11 in CPE cells and U937 macrop(Fig. 5a). Used at 12 mg/mL compound 3 caused on U937 macro-
phages a reduction of living cells of about 36% while compound 11
did not cause any cytotoxic effect (Fig. 5b).
3.4. Morphological alterations
Morphological alterations induced in parasites by the treatment
with compound 3 and 11 were evaluated using a ﬂuorescence
microscope after labeling with acridine orange and ethidium bro-
mide. The untreated parasites showed green ﬂuorescence and
classical morphology being slender, elongated and ﬂagellated
(Fig. 6a). Promastigotes treated with compound 3 or 11 revealed
morphological changes that share many characteristics with
apoptotic death of the metazoans (cell shrinkage, cytoplasmic and
nuclear condensation) (Fig. 6b and 6c). The percentage of cells
showing morphological alterations was correlated with the con-
centration of each drug (data not shown). After 48 h exposure to
10 mg/mL 3 or 11 the percentage of promastigotes with morpho-
logical alterations was 80% and 98% respectively; in contrast,
macrophages exposed 48 h to 10 mg/mL 3 or 11 do not show any
morphological change compared to the control (data not shown).
Therefore, compounds 3 and 11were able to induce morphological
aspects of apoptosis only in parasites and not in macrophages. To
conﬁrm these data the Annexin V assay was carried out on Leish-
mania infantum promastigotes and macrophages.
3.5. Apoptosis in leishmania promastigotes cells
The Annexin V assay provides a simple and effective method to
detect apoptosis or necrosis. This assay takes advantage on the fact
that: (i) phosphatidylserine (PS) is translocated from the inner
(cytoplasmic) leaﬂet of the plasma membrane to the outer (cell
surface) leaﬂet soon after the induction of apoptosis, and (ii) the
Annexin V protein has a strong and speciﬁc afﬁnity for PS. Staining
with Annexin V was used in conjunction with propidium iodide
(PI), for identiﬁcation of early apoptotic, late apoptotic and necrotic
cells. Flow cytometric detection of Annexin V positive cells iden-
tiﬁes the percentage of cells that are in early (Annexin V positive
cells in lower right quadrant) and late apoptosis (Annexin V and PI
positive cells double stained in the upper right quadrant); Annexin
V negative/PI positive cells identiﬁes the percentage of necrotic
cells. As shown in Fig. 7, treatment of parasites with 10 mg/mL
compound 3 (Fig. 7b) and compound 11 (Fig. 7c) for 48 h induced PS
externalization (increase of cells in the right quadrants of the ﬂow
cytometric dot plot) indicating that the cause of parasite death is
the activation of apoptosis. In contrast, these compounds did not
induce any PS externalization in macrophages (Fig. 7 def).hages. Bars indicate the mean ± SE from four independent experiments.
Fig. 6. Morphologic changes observed in Leishmania infantum after exposure to
compounds 3 and 11. Live parasites were determined by the uptake of acridine orange
(green ﬂuorescence) and exclusion of ethidium bromide (red ﬂuorescence). Dead
parasites was determined by the uptake of ethidium bromide (red ﬂuorescence). (a)
Control; (b) promastigotes exposed to 10 mg/mL of compound 3 for 48 h; c) promas-
tigotes exposed to 10 mg/mL of compound 11 for 48 h. Apoptotic parasites show a loss
of volume and nuclear condensation. Green arrows indicate living parasites, yellow
arrow early apoptotic parasites and red arrow late apoptotic parasites. (For interpre-
tation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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The effects of 3 and 11 on cell cycle distribution was analyzed in
Leishmania infantum promastigotes. Cells were cultured in presence
of 10 mg/mL of each compound for 24 h. Flow cytometric analysis of
cell cycle was carried out after staining of parasites with propidium
iodide. Fig. 8a illustrates histogram of propidium iodide-stained log
phase promastigotes. As shown, 51% of the growing parasite pop-
ulation is in G1, 30% in S, and 19% in the G2/M phase. The resem-
blance of the DNA distribution pattern indicates that parasites are
stably growing populations. Trans-stilbene derivative 3 induced the
arrest of Leishmania promastigotes prevalently in G2/M phase
(Fig. 8b) while the terphenyl compound 11 in G1 phase of cell cycle
(Fig. 8c). Cell cycle analysis depicts the effect of different treatments
on progression of cell cycle wherein presence of cells in sub G0eG1
phase indicates the occurrence of apoptosis. Compounds 3 and 11triggered apoptosis in Leishmania infantum promastigotes with an
increase in sub G0eG1 population to 21.5%, and 32.6% respectively
in comparison to untreated parasite control where only 6% cells
were found to be apoptotic.
4. Discussion
Recently, several studies have shown that stilbene based com-
pounds are endowed with antileishmanial activity (del Rey et al.,
1999; del Olmo et al., 2001; Getti et al., 2006; de Almeida
Machado et al., 2015; Fuchino et al., 2013). Since these molecules
are generally non toxic and well tolerated in vivo, they may
represent an interesting alternative to the currently antileishmanial
therapy (Baur and Sinclair, 2006; Kee et al., 2014; Li et al., 2014). In a
previous work, we studied a series of cis- and trans-resveratrol
bearing 3,5-dimetoxy motif at the A phenyl ring and amino,
methoxy and hydroxyl function at 30- and/or 40-position. TTAS was
the most active stilbene showing in Leishmania infantum a IC50
value of 2.6 mg/mL, comparable to that of pentavalent antimonial
sodium stibogluconate (pentostam) that we used as a reference
compound (Tolomeo et al., 2013). To further explore the SAR of this
class of compounds we studied herein a second series of trans-
stilbenes derivatives in which a variety of substituents were
introduced at positions 20, 30and 40 of the stilbene scaffold while the
3,5-dimethoxy motif was maintained (2e5, Fig. 1, Table 1). Addi-
tionally, in an attempt to increase the chemical diversity of the
compounds we studied a series of terphenyl derivatives (6e12,
Fig. 1, Table 1) that notably do not bear the ethylene double bond
that is the main reason for the chemical andmetabolic instability of
the stilbene derivatives (Metzler and Neumann, 1977; Metzler,
1975).
Initially all the compounds were tested in vitro against Leish-
mania infantum promastigotes in comparison with pentostam and
with TTAS and resveratrol as reference compounds (Table 1). All
stilbenes studied in this work (2e5, Table 1) were endowed with
antileishmanial activity. Compound 3, lacking the 30-amino group
was the most active showing on promastigotes a leishmanicidal
activity comparable to pentostam and the parent TTAS, suggesting
that the 30-amino function is not necessary for the activity. Differ-
ently when the 40-methoxy function of TTAS was replaced by the
amino group as in compound 2 the activity decreased. A detri-
mental effect on the potency was also obtained with stilbenes 4 e 5
bearing an hydroxy group at C20 and a methoxy function at C-40 or
C-30 respectively.
Among the terphenyl series the range of activity was very wide.
Derivatives, 6, 8, and 12, which may be considered resveratrol an-
alogues, showed an IC50 higher than 50 mg/mL. Terphenyls 7, 9 and
11, analogues of pterostilbene (IC50 7.3 mg/mL) (Tolomeo et al.,
2013) maintained the anti-leishmanial activity showing an IC50 of
5.3, 3.8 and 1.4 mg/mL respectively. Terpenyl 11was themost potent
compound of the series displaying an antileishmanial activity on
promastigotes higher than the parent stilbene 3, TTAS and pen-
tostam. Therefore, these results indicate that the introduction of
methoxy group at the stilbene resveratrol motif and to its terphenyl
analogues seems to be important to confer a good antileishmanial
activity to this class of compounds; in fact, in our cases themethoxy
derivatives were more active than the corresponding phenols
(compare 3 vs resveratrol, 11 vs 12).
Compound 11 was highly active in amastigotes and in intra-
macrophagic amastigotes but was no toxic in normal cells and in
macrophages. Of interest, a treatment with 10 mg/mL compound 11
for 48 h was able to eliminate completely intramacrophagic
amastigotes without inducing any cytotoxicity on macrophages.
Cell cycle analysis showed that 11 causes an arrest of parasites in
G1 phase of cell cycle while compound 3 in G2/M. Moreover, an
Fig. 7. Flow cytometry analysis of Leishmania infantum promastigotes (aec) and U937 macrophage cells (def) following treatment with 10 mg/mL of compound 3 (b, e) and
compound 11 (c, f) for 48 h. Control cells, parasites (a) and macrophages (d), were not exposed to the compounds. The cells were stained with Annexin V and Propidium iodide (PI).
Lower left quadrant belongs to control cells (Annexin V negative/PI negative), lower right quadrant belongs to early apoptotic cells (Annexin V positive/PI negative), upper right
quadrant belongs to late apoptotic cells (Annexin V positive/PI positive), upper left quadrant belongs to necrotic cells (Annexin V negative/PI positive). Data are representative of
three separate experiments.
Fig. 8. Effects of compound 3 and 11 on DNA content/parasite following treatment of promastigotes for 24 h. The parasites were cultured without compound (control) (a) or with
8 mg/mL compound 3 (b) and 11 (c). Cell cycle distribution was analyzed by the standard propidium iodide procedure. Sub-G1 (A), G1, S, and G2eM cells are indicated in (a). Data are
representative of three separate experiments.
G. Castelli et al. / Experimental Parasitology 166 (2016) 1e98apototic sub-G1 peak was observed in both samples treatedwith 11
and 3, although the percentage of cells in sub-G1 was higher in the
sample treated with 11. Apoptosis was conﬁrmed bymorphologicalexamination and Annexin V test; in both the percentage of
apoptosis was higher in the samples treated with compound 11. In
contrast, no apoptotic effects were observed in human
G. Castelli et al. / Experimental Parasitology 166 (2016) 1e9 9macrophages. Apoptosis is an irreversible cell death process and
drugs able to activate apoptosis can eliminate deﬁnitively parasites
or cells of multicellular organisms. The ability of 11 and 3 to induce
apoptosis in Leishmanias saving macrophages conﬁrm the selective
activity of these compounds.
In conclusion, we ﬁrstly demonstrated that compounds
belonging to the class of terphenyls, as well as stilbene compouds,
can be endowed with antileishmanial activity. This activity was
potentiated by the introduction of methoxy groups. Terphenyl 11
was the most active compound displaying a leishmanicidal activity
greater than stilbenes and pentostam. The ability of 11 to induce
selectively apoptosis in parasites while saving macrophagic cells
and its low toxicity on normal cells makes this compound inter-
esting for further clinical and biological studies.
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